TW200824744A - Integrated coil apparatus and method for using same - Google Patents

Abstract

An apparatus and method for electromagnetic treatment for treatment of molecules, cells, tissues, and organs comprising: configuring at least one waveform according to a mathematical model having at least one waveform parameter, said at least one waveform to be coupled to a target pathway structure (STEP 101); choosing a value of said at least one waveform parameter so that said at least waveform is configured to be detectable in said target pathway structure above background activity in said target pathway structure (STEP 102); generating an electromagnetic signal from said configured at least one waveform(STEP 103); integrating at least one coupling device with a positioning device to be placed in proximity to said target pathway structure(STEP 104); and coupling said electromagnetic signal to said target pathway structure using a coupling device(STEP 105).

Description

200824744 TPPO/PUS213-001 IX. Description of the invention: [Technical field of invention] This case is an integration--slave and new, special reduction magnetic hybrid coil device and method 'to achieve cell by applying electromagnetic information And the organization of growth adjustment, repair, 隹k body and behavior of the wood, especially the application of non-invasively combined electromagnetic signals K, "the number of body knives. This case also deals with the treatment of the interaction between the living tissue and the cells and their electromagnetic environment. In this case, a specific embodiment is proposed in the case of a fourth (fourth) squatting, repairing, maintaining, and general behavior of a lie-coded electromagnetic dysfunction. This embodiment uses an inductive method according to the current invention ( Such as coils) transmit pulsed electromagnetic fields (" legs to strengthen the living tissue into other components such as support, windings, beds, wheelchairs, and in combination with other curative and healthy physical therapies, heat, cold, massage, etc. [Prior Art &Applications have been developed by the weak non-thermal magnetic field (EMF) to produce physiologically significant in vivo and in vitro biological effects. ,,,,,,,,,,,,,,,,,,,,,, The use of the bone repair signal stems from the consideration of the ι axis: ι ι constituting a way to properly correspond to the leg signal. A linear physicochemical method using cell membrane electrochemical models predicts possible Bio 5 200824744 TPPO/PUS213-001 The range of EMF waveform patterns of effect. Because the cell membrane is the possible "mesh furnace", it must be induced by an electrochemical method on the cell surface. The range of waveform parameters, such as the dynamics of voltage dependence. The extension of this linear mode also involves the analysis of the force of a pulse. The frequency of a pulse of radio waves transmitted by a continuous sine wave of 27.12 is used in the healing of deep biopsies. It has been widely known in previous electrotherapy techniques. The pulse of the electroacoustic number ^ was originally thought to be an electromagnetic mushroom field that can cause non-thermal biological effects in infection therapy. P (four) therapy is known to be used in reducing trauma and surgery. Pain and reduction of edema in soft tissue, wound healing, burn treatment and nerve reconstruction. The use of biliary examination for traumatic edema has been widely used in recent years. PRF has been used in animal and clinical research to point out that edema can be made through such electromagnetic stimulation. The previous-dosimetry technique did not consider the relationship between the dielectric properties of the tissue structure and the dielectric properties of the independent cells. In recent years, the use of non-invasive pRp in the radio wave band clinically, including the right to use I2 MHz sine wave burst, where each burst contains 65 microseconds of visibility. The fixed dog has about 1700 sinusoidal cycles. And there are different repetition rates. This limited frequency composition can be combined with the relevant dielectric paths in cells and tissues. Time Wei magnetic field - contains square wave, square wave, or both square wave and square wave waveform, Such as _ modulation electromagnetic field; and sinusoidal waveform, such as surface radio frequency field (outline _

Hz _ 15 to 4 OTz is clinically useful as an adjunct to the treatment of various facial bone injuries. 200824744 TPPO/PUS213-00! Since the 1960s, the development of modern treatment and disease prevention devices has been stimulated by clinical rupture problems involving non-combined and delayed bone. Early suspicion indicates that the electronic path can be a method that allows the bone to adaptively correspond to mechanical input. Early electrotherapy devices used implantable and semi-invasive electrodes to deliver direct current (τ) to a rupture zone and then developed into electrical and electromagnetic fields. These therapies were originally used to provide a non-invasive "contactless" ‘induction of electrical/mechanical waveforms at the cell/tissue level. The clinical application of these techniques has been improved in continuum surgery through rupture treatments around the world, such as treatment of rupture and new rupture, and spinal joints. At present, there are several devices that treat bribes and ruptures. The power consumption of these devices is unpredictable. The ambiguous Longdu Club has been recommended to be a safe, non-surgical, non-invasive first-sub-bone-plant alternative. The other side of these 2 techniques showed side-by-side blood test, double-fertility study, tendonitis, bone closure, fire repair, blood circulation and arthritis pain, and other physiologic bones. There have been reports. The study of -1 and Chengcheng determined the role of weak low-frequency electromagnetic fields in signal transduction pathways and growth factor synthesis. Studies have shown that after a short, trigger-like period, win = long-term secretion. The binding process of the ion/coordination in the cell membrane is generally considered to be EMF 0 , which is a modulation-like expression of the normal molecular regulatory portion of bone repair.曰 Ί level studies have shown the role of neutrophil transport, cell diffusion, 7200824744 TPPO/PUS213-001 insulin growth factor (n IGF-IΓ) release, and IGF-II receptors in osteoblasts. The effect on insulin growth factor-I ("IGF-Γ') and IGF-inhibition was also verified in rat ruptured pseudo-osteogen. Stimulation of PEMF-converting growth factor beta ("TGF-β") message ribonucleic acid ("_A,") has been revealed in a rat bone-inducing model. The results show that TGF-/3 mRNA is designated by MG -63 people resemble osteoblast lines to increase the amount of expression's in which there is an increase in TGF-/31, collagen, and osteosynthesis synthesis. pE Xinjiang stimulates hypertrophy and atrophy in human non-combined tissues The increase in TGF-/31. Further, the spring study demonstrated an increase in protein in TGF-/51 mRNA and osteoblast cultures due to the direct effect of EMF in a _/pro-dependent pathway. The chondrocyte study showed a similar increase in TGF-/31 _A and proteins synthesized by EMF', indicating a therapeutic application for joint repair. Various studies have indicated that the production of growth factor production is increased, perhaps a Potential tissue-level mechanism Common denominator of electromagnetic stimulation. When using specific inhibitors, EMF may pass a calciton-dependent pathway. First rain studies indicate that specific PEMF and prf signals and weak static magnets In the field, in a non-cell enzyme preparation, the milk will be adjusted. In addition, the interesting w of Cong and Teng* is accompanied by an increase in the expression of osteoblast culture, and the wealth in the bones and cartilage—as with the “PEMF” The increase in performance has been explained and illustrated by experiments. However, the prior art does not use an inducing device in this field - a programmable, lightweight, portable, disposable, implantable, composable, built-in based on a number-type signal. , or at least attached to clothing, fashion accessories, foot wear, end belts, holders, anatomical windings, clothing, cushions, mattresses, pads, wheelchairs, treatment beds, 8 200824744 TPPO/PUS213-001 treatment chair, treatment And health maintenance equipment such as vacuum assisted wound closure devices, mechanical and functional electronic stimulation devices and exercise equipment, or ultrasound, heat, cold, massage, and exercise. Further demands for "therapeutic induction devices and methods thereof are lightweight, portable, implantable, and disposable. For an electromagnetic therapy-inducing device and method, a further step-by-step requirement is that there is less need for God and non-invasiveness. This feature allows for an enhanced signal integration in surgical dressing, wound dressing, padding. , sitting, mattresses, shoes, and other garments or structures incorporated into living tissue and cells, even integrated into the _ creation of clothing to deliver enhanced EMF signals to all parts of the body and transmit signals according to mathematical models, and Stylized. SUMMARY OF THE INVENTION The purpose of the present invention is to propose that the electromagnetic therapy integrated into the treatment and non-therapeutic apparatus induces slaves and - green-riding _ age-of-life _ shape to change the interaction between living tissue and cells and their electromagnetic environment. treatment. 10 In order to achieve the above object, a specific embodiment is proposed, which is processed by a flow path for an optional body region, the flow path comprising a minimum width characteristic which is at least approximately in the burst burst packet. Seconds, with about '100'000 pulses per burst, wherein the voltage amplitude envelope of the aforementioned burst is defined by an arbitrarily varying parameter 'its instantaneous minimum amplitude is not less than one tenth of its s large amplitude proportion. The pulse burst repetition rate can be from about 0. 〇1 to about 1 〇, _ machine. A mathematically definable parameter can also be used to define the amplitude envelope of the aforementioned burst of pulses. By increasing the frequency range of transmission to the relevant cellular pathways, a wide range of 200824744 TPPO/PUS213-001 physics can be applied to known healing mechanisms, including enhanced __ raw and growth factors and cytokines Release so that this purpose can be achieved. According to a specific embodiment proposed in the present case, the unipolar or bipolar square or sinusoidal pulse bursts or induced electric field peaks at 'to 10 volts per PCT tank cm' by arbitrarily or other high spectrally dense 匕. The sinusoidal pulse, a more efficient and imaginative effect, can be achieved in the healing process of soft and hard tissues suitable for humans, animals and plants. Pulse burst packets with a more southern spectral density can be advantageously and efficiently combined with physiologically relevant > dielectric pathways, such as cell membrane receptors, ionic bonding with cellular enzymes, and general transmembrane potential changes, thereby modulating angiogenesis The action and neovascularization are advantageously applied as a parameter of a high spectral density as a parameter defined by an adjustment or burst of pulses, the power requirement of which can be significantly lower than that of the unmodulated pulse. This _ cell/molecular process matches more efficiently. Accordingly, a double cake is added to the associated dielectric path to enhance the delivered dose and reduce the power requirement. In this case, the signal noise ratio (,, powers service) of the paste power of the embodiment is configured to combine the bio-effects with the miniaturized circuit and the lightweight elastic coil. It advantageously allows the device to be powered by a SNR, a miniaturized circuit, and a lightweight, flexible coil' that is fully portable and can be made disposable and further customizable as needed. The lightweight elastic coil may be an integral part of a suitable device (such as surgical bag shoes, wheelchairs, chairs, and other garments and structures that come into contact with living tissue and cells). Through the effective integration of the whole - crane as a preparation, chat and school finances mixed 200824744 TPPO / PUS213-001 treatment.

A 200 microsecond symmetric or asymmetrical pulse repeats within approximately 〇1. The canine hair packet is a modulated l/f function and is used between 1000 Hz. Specifically, 'Lai Bo _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Use a single amplitude/power comparison with the age of a path structure to reduce the micro-shape. The bursting of the frequency of the Qiu, rectangular, and mixed waveforms of the arbitrary waveforms is shown to be about 1 to about 100,000 bursts per second, and from about 0.01 to about 1000. The burst/mother dog's fascination L signal amplitude is in a target path structure (eg tissue) in the range of about wcm to moo mV/cm. Each side burst burst may be an arbitrary function that provides a way to make the healing tissue a variety of different electromagnetic touches. The preferred embodiment of the present invention includes a pulse burst of about Π to about (10) milliseconds including a random repetition rate of about i to about 100 kHz at a burst of about 〇 1 and about a fixed repetition rate. It is used between about i. Hertz and about 1 Hz. An induced electric field is generated from about 001 001 mV/απ to about (10) mV/cm. One of the examples proposed in this case contains - about 〇. G1 milliseconds to about 1G milliseconds of high drunkenness bursts (such as 27.12 MHz) 'heavy_about i to about just bursts per second. Produces an induced electric field about . OOi mV/cm to about mV/cm. The waveform may be transmitted by the inductive or capacitive coupling. The invention further proposes a living cell and a group-electromagnetic treatment method comprising a 200824744 t-frequency 'high spectral density electromagnetic field. 3 00 Electromagnetic treatment of living cells and tissues, and includes a + = a fine concealed flap, _ Wei Jing no cell or ^ A dare to correlate with EMF-sensitive path coupling. = Configure a pass-to-noise noise ratio c, snr ") Analytical mathematical simulation of the wave-on-wave spectrum" to configure a waveform that ideally regulates blood The output of the new and new blood vessels is provided by a waveform configuration device (such as a miniaturized electronic circuit), and the output δ is prepared (for example, an ultra-lightweight coil) to face the configuration waveform. One (4) proposes a lightweight elastic coil, However, it is integrated into at least the following / accessories, accessories, foot wear, end belts, anatomical support, anatomical package purple, = sitting, mattress, mattress, wheelchair, wire, treatment chair, treatment and health Maintenance 2. If the real worker assists the wound surface equipment, the mechanical and Wei electronic stimulation reading and the East Spear 匕糸 'to deliver the ideal of the above-mentioned optimal non-invasive electromagnetic pulse treatment, to strengthen in animals, people And the repair and growth of living tissue in plants. The invention further proposes - the method of transmitting a waveform configured by a snr/p. analysis of the target path structure in a programmable manner, for example according to a time-dose program, a series of pulses or other Random or designed sequence. The present invention further provides a method for generating a signal from a waveform that is configured by the target = configuration, to be stalkable, such as according to time - μ A series of pulses, or other sequences that are designed or designed. X month is also proposed - method to provide multiple coils, transmitting waveforms configured by the target path structure of 12 200824744 TPPO/PUS213-001 SNR/Power analysis to increase the therapeutic coverage area The invention further proposes a method for providing multiple coils which are driven simultaneously or continuously (for example, multiplex communication), with the same or different above-mentioned optimal groups. The present invention is more difficult to touch and lighter. Wei system, Wei brewing by incorporating the line-focus EMF signal into the affected tissue, passes the waveform configured by the SNR/P〇wer analysis of the target path structure into the ergonomic support garment. 'This is more proposed - method to The scale line creates a daily reliance, and integrates a coiled • Active Sportswear' to transmit the waveform configured by the SNR/Power analysis of the target path structure, placed in close proximity to an anatomical target. The invention further proposes that the method transmits the beach signal to the affected tissue by means of a lightweight elastic coil or wire, and combines the coil or the wire as a whole part of the various shapes/knifes to prepare for compression, elasticity, cold compression and heat. The compression and delivery are waveforms configured by SNR/Power analysis of the target heterostructure. Turtle The present invention further proposes a method to increase the trace coverage area by using a plurality of coils, configured by a SNR/P0wer analysis of the target path structure. " The invention further proposes a method for making a coil, using a wire, to deliver a waveform configured by an SNR/P〇wer analysis of a target path structure. ^Inventively proposed - method to make a coil, using a thin elastic wire, to transmit a waveform configured by an SNR/Power analysis of a viewing path structure. This method is also proposed to provide the same or different waveforms of the target path structure by the same or different waveforms, simultaneously or continuously supplying single or multiple coils. 13 200824744 TPPO/PUS213-001 Injury treatment - and Was used to make the Θ Θ 与 与 与 标准 标准 WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU WU Configured waveforms that are integrated into the treatment couch, treatment chair, and wheelchair. The method provides a waveform of the s_〇wer miscellaneous configuration of the coil that transmits the surface path of the smear, which is integrated on various therapeutic surfaces, such as pressure relief, verifiable, flow, rotation, and air flow. surface. This month, another method is proposed to provide a coil that transmits a waveform configured by SNR/Power analysis of the target path structure, which is integrated into a therapeutic sitting such as an expandable, fluidized, foam cushion. The present invention further proposes a method for providing, _ which transmits a waveform configured by a target path __S^P〇Wer, which is integrated in at least one of: - treating a mattress cover, sheets, blankets, pillows, Pillow boxes, treatments that may impose a smooth or intermittent pressure, such as air-clearing vests. The handle further proposes a method such that the flux path can be included in any of the treatment surfaces, the structure 'or device' by transmitting a wave 14 200824744 / TPP_S213 profile configured for the SNR/p〇wer analysis of the target path structure to enhance the treatment The effect of surface, structure or preparation. The present invention further provides a method for incorporating a coil of a waveform configured by SNR/Power analysis of a target path structure into a footwear such as a shoe. The present invention further proposes a method for integrating at least the arbitrarily configured analysis coffee to integrate the sales and processing to improve the efficiency of the therapeutic surface, structure or device. 'This issue (4) proposes that the square touch will at least pass the waveform configured by the SNR/power analysis of the pair-target _ junction's structure, integrated in at least one of the ruled surface, the -2 rule 2 structure, and a treatment The device 'to enhance the effects of at least one therapeutic surface, therapeutic structure, and therapeutic device to prevent loss and deterioration of cells and tissues. The present invention further provides that the waveform of the SNR/P〇wer analysis configuration of at least one of the at least one treatment surface is integrated into at least one treatment surface, a treatment structure, and a treatment device to improve At least one effect of the silk surface, therapeutic structure, and treatment equipment to increase cell and tissue activity. The present invention further proposes a method for integrating at least the waveform of the SNR/Powei' analysis configuration of the coil-synchronized path structure into at least one treatment surface, a treatment structure, and a treatment device. To increase the effect of at least one therapeutic surface, therapeutic structure, and therapeutic device to increase the amount of cells. The invention further proposes a method for transmitting at least one coil by a waveform configured for SNR/P〇wer analysis of a target heterostructure, integrated in at least one gamma surface, a treatment structure, and a treatment device 'To enhance the effects of at least one therapeutic surface, therapeutic structure, and treatment equipment for 200824744 TPPO/PUS213-001 to prevent neuronal deterioration. The invention further proposes that the method at least ___ transmits a waveform of the s_ower analysis configuration of a target path structure, integrated in at least one of the ruled surface, a therapeutic structure, and a treatment device to enhance at least one therapeutic surface The effects of treatment structures, and therapeutic devices to increase the number of neurons. The other touch-method of the present invention at least _ transmits the waveform of the SNR/Power analysis configuration of the target path junction, and integrates the effect on at least one of the treatment surfaces and the treatment device to prevent the on-side I Deterioration of neurons in the surface region of adrenaline. The invention further proposes - method (10) at least - line transfer of a waveform configured by SNR/P〇wer analysis of a target path structure 'integrated on at least one treatment surface, one treatment structure' and one treatment device to enhance at least one treatment The effect of silk surface, therapeutic structure, and therapeutic equipment 'to increase the number of neurons in the brain surface area of adrenaline. The invention of the invention and the invention of the invention are as follows. ‘Embodiment】 The induced time-varying current flows from the PEMF or PRF device to a target path structure such as molecules, cells, tissues, and organs, and this is a current that stimulates cells and tissues to produce meaningful physiological responses. The target path structure electrical properties induce the level and distribution of current. Molecules, cells, tissues, and organs are all in an inductive current path, such as thin 16 200824744 TPPO/PUS213-001 Cells are connected at -_ junction. Ion or ligand interaction side table _ macromolecular bond position is · · touch, is electrochemical, may produce - an electromagnetic field (nE ") 〇 induced current through a surrounding ion medium to reach these areas. Cells appear in the - current path leading to induced current ("j") decaying more rapidly over time (J(t)). The electrical and valley-time junctions and other electro-sensitive membrane processes such as membrane transporters And increase the electronic impedance of the cells. Effective electronic · _ its record of money and Lai interface configuration has been . #export. For example, in the calcium ion ("coffee" bond, the concentration change of Ca2+ combined in the bonding region due to the induction of enthalpy can be expressed as an impedance table. The scale field is expressed as: z»Rion+~^~, which has a series resistance capacitor The form of the electronic equivalent circuit. 1 is the angle is defined as 2 pairs, f is the frequency, i = _n Zb (〇) is the bond impedance, and she and "is the equivalent bond of the ion bond junction Resistance and capacitance. Equivalent relay time constant value Γί〇η=ΚΐΧαΐ and ion bond rate constant, Lingguan, by r, H1/kb. Therefore, the time-time of this path is determined by the Xuanjian wheel mechanics. The E induced from the PEMF or PRF signal may cause current to flow into the ionic bond junction and affect the number of (10) ions per unit time. Its circuit equivalence is a direct measurement across the equivalent junction residual voltage, which is a direct measurement of the charge change stored at C(10). The electricity is directly proportional to the surface concentration of the _ ion in the bonding region, and its charge is stored with ions or other hoofs. The electronic impedance measurement provides a value for the configuration of the necessary ρΜρ waveform to match the bandpass of the target path structure with 17 200824744 TPPO/PUS213-001 and for the bond rate constant _ kinetic analysis. This allows a necessary range of frequencies 'to-to-specified inductive E waveforms to ideally couple to the target impedance, such as bandpass. The ionic bond with the control molecule is a frequent ΕΜ target, such as the condition + bond modulating (CaM). The purpose of this k-path is based on force sigma tissue repair, such as bone repair, 'X-injury repair, hair repair, or other molecules, cells, tissues, and organs involved in the growth of the genus. . Growth factors such as platelet-derived growth factor (''PDGF''), fibroblast growth factor ("FGF"), and epidermal growth factor ("^ are all involved in an appropriate healing phase. Angiogenesis and neovascularization The role is also part of the organization's growth and repair, and can be adjusted by the PMF. All of these factors are Ca/CaM dependent. A waveform can be configured using the Ca/CaM path, and the inductive power is sufficiently greater than the background thermal noise power. In the correct physiological situation, this waveform can have a physiologically important biological effect. 10 Power SNR model for Ca/CaM application requires electronic equivalence knowledge of Ca2+ bonding dynamics in CaM. In junction kinetics, the concentration of the junction position over time may be described in the frequency domain via an equivalent bond time constant ' ΙΈ RionCion , where L and Cion are the equivalent bond resistances and capacitances of the ionic bond junction. Associated with the ionic bond rate constant, kb, by riaF Ri〇nCi〇n = 1; / kb • published kb values can then be used in cell array models to assess SNR, by comparing PRF The signal induced voltage fluctuates with the thermal voltage at the CaM bonding position. The value is used to represent the layer reaction, such as 18 200824744 TPPO/PUS213-001 V^B.SxlO'sec1, [Ca2+]=2.5UM, ^ΟμΜ, [〇^ Μ]=Κ,([〇β2+]+[〇βΜ]), yield Μ65 sec] = l. 5 msec)·. This "value can be used in an electronic equivalent circuit for ionic bonding" when Power SNR analysis can perform any of the waveform structures. According to an embodiment of the invention, a mathematical model can be described to understand that thermal noise is present in All of the dependencies are mixed, and the silk is the best SNR. The power spectral density of the thermal noise, Sn((〇), can be expressed as: where ΖΜ(Χ,ω) is the electronic impedance of the target path structure, χ is the dimension of the target path structure, and Re represents the real part of the impedance of the target path structure. ΖΜ(χ,ω) can be expressed as:

Zui^co)

Re+Ri + Re r tanh(^c) This equation is clear _ indicates the target path structure of Xuanyuan, and cell dislocation electric 妃), the resistance of the intracellular fluid ("Ri") and cell membrane resistance (10)") It is connected to the target path structure by the circuit ^^, which is caused by the noise. (10) ― A typical method for SNR evaluation uses the _ noise light one = value. The calculation method is An integer is the sum of the square root of the phase and the end of the response, or the frequency of the target path structure.

RMS where IW i is the maximum voltage amplitude of the TPPO/PUS213-001. One embodiment of the present invention includes a burst of high spectral density bursts, whereby the effect of the therapy on the associated dielectric pathway (e.g., cell membrane receptors, ion-to-cell enzyme bonding, and general transmembrane potential changes) is enhanced. . Moreover, by increasing the amount of fresh components that are conveyed to the _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ The organization growth mechanism can be achieved. 'Luben's - implementation of the ship - depreciation, it is high _ bribe package, applied to the series of sudden packet unipolar seam or positive rushing its peak electric field nano 108 to about just v / cm, applicable to soft And hard tissue produces better results for the biological recovery process. A is applied by the application of a high-wave spectral density voltage packet, or the spurt is more than the tumbling of the money. The amount of energy can be significantly greater than that of the unmodulated pulse that contains the pulse in her fresh range: = a large reduction due to ΓΓ峨Repeated burst long column = take, and the amplitude of the Zhao machine is in the burst of the pulse burst. Relative _ can be = _ off the electrical interest and reduce the power demand, this double to avoid 2 = 1 class - f miscellaneous, blame, this subs = = = standard path structure 'such as human and animal ion and coordination, fine and prevent disease use. A mathematical model with at least one waveform 20 200824744 TPPO The /PUS213-001 parameter is used to configure at least one waveform to be covered by a target path structure such as an ion and a ligand (step 101). The configured waveform satisfies the P〇wer SNR model for a specified and known target The path structure may select at least one waveform parameter such that the waveform is active in its background (eg, the bottom line of the voltage, the thermal fluctuation, and the electronic impedance of the target path structure depending on the state of the cell and the tissue, the state being at least rest, growth, replacement, and hurt Above one of the responses is detectable (steps 1〇2).

A preferred embodiment of the present invention for generating an electromagnetic signal comprising an arbitrary waveform burst having at least one waveform parameter comprising a plurality of frequencies comprising a range from about 〇.〇1 Hz to about 100 MHz, wherein the plurality of frequencies The composition satisfies the p〇wer SNR model (step 102). Can be generated by means of inductors or capacitors - New Zealand electromagnetic signals, as mentioned above,

To configure at least the waveform (step (10)). The electromagnetic signal is lightly coupled to a target path structure (such as ions and ligands) and placed at a position close to the target path structure via an output device (such as an electrode or sensor) (steps 1〇4) , using a positioning sigh, by coupling the coupling device with the positioning device (steps. The combination will increase the _ sub and _ sub-combination _, cells, and _ combination of the young. Faced tender, wound dressing The ancient Γ, mattress 塾, shoes, wheelchair, chair, and can be placed in the living tissue and cells = the structure and structure. Integration _ and positioning equipment has the advantage that the treatment can be ordered at 0. In any place and time. 200824744 TPPO/PUS213-001 wire) combined with 'control circuit can also operate wirelessly. The opposite ends of at least one of the connectors are combined with a generating device such as an electrical coil 203. The micro control circuit 201 is fabricated by a method of applying a mathematical model for forming a waveform. The configured waveform must satisfy the p〇wer model so that for a given and known target path structure, the waveform parameters that satisfy the Power SNR can be selected so that the waveform can be detected above the background activity of the target path structure. A preferred embodiment of the present invention applies a mathematical model to induce a time-varying magnetic field and a time-varying electric field in a target path structure (such as ions and ligands), comprising a burst of about 1 to about 1 millisecond, which has Approximately 1 to about microseconds, repeating a rectangular pulse of about 0.1 to about 1 pulse per second. The electric field peak amplitude of the induced electric field is between about 1 uV/cm and about (10) mV/cm' as a function of a modified 1/f function, where f = frequency. In the preferred embodiment of the present invention, the configured waveform may be applied to a target path structure such as ions and ligands, for a continuous-better total exposure time of from 1 minute to 24 minutes per day. Other exposure times can also be used. The waveforms configured by the micro control circuit 2Q1 are directly connected to a generating device 2〇3 such as an electric coil through the connector 202. The generating device 2〇3 delivers a pulsed magnetic field that is configured to provide treatment for a target contact structure, such as a skin tissue. The micro-wei machine turns over-dirty in a time interval and can automatically apply a pulsed magnetic field to all required uses, for example, 10 times per day. Micro-control Mu Shu can edit the ball when reading __ application pulse impulse magnetic field. The nuclear-fighting supplement can be continued—a neo-integration is used in the treatment of the hair, so the component is independent. Combining a pulsed magnetic field with a 22 222424 TPPO/PUS213-001 diameter structure such as ions and ligands reduces inflammation in treatment and prevention, thus reducing pain and promoting healing in the treatment area. When the electric coil is used as the generating device 2〇3, the electronic coil can be powered by a time-varying magnetic field that induces a time-varying electric field in the target path structure according to Faraday's law. An electromagnetic signal produced by the brain of the generating device can also use a heterojunction, where the electrode is the conductive boundary of the cake portion of the skin that is in contact with the skin or target path. In another embodiment of the present invention, the electromagnetic signal generated by the generating device 2〇3 can also use the static 4 junction 'where the air gap exists in one of the generating injuries (such as an electrode). The advantage is that the fine __σ small turtle The electricity can be used in any kind of physical growth, analgesia, and tissue and organ healing. An advantageous result of applying the preferred embodiment of the present invention is that tissue growth, repair, and maintenance can be accomplished or enhanced anywhere and at any time. The maintenance of the growth, repair, and maintenance of molecules, cells, tissues, and organs using the preferred embodiment of the present invention can be accomplished or enhanced anywhere and at any time. FIG. 3 is a structural diagram of a micro control circuit of a preferred embodiment of the present invention. Miniature = 17 waveform, its lining - production butterfly such as ® 2 " 〇, 例路路300 has a power supply such as clock battery 301. The preferred implementation of the power supply source i y - 7 voltage, but other voltages can be used. In another embodiment of the present invention, the external source of electrical power, such as a current outlet, such as an AC/DC outlet, is circulated through, for example, a socket and a wire, and the combination of the invention and the invention. A variable power supply 3〇2 controls the micro 23 200824744 ' _ TPPO/PUS213-001 100pL parts into the ι · 5ml Eppendorf test tube. All Eppendorf tubes contained the reaction mixture which was kept in a helium fly and then transferred to a water bath that was specifically designed to maintain a 37 ± 0. 1 C constant perfusion of water preheated via a Fisher Scientific Model 900 heat exchanger. The temperature is monitored with a thermistor probe such as Model 811〇2〇 and immersed in an Eppend〇rf tube during all runs. The reaction was initiated by 2·5|J [32P ATP] and terminated by a Laemmli sample buffer solution containing 30 · Μ _. The minimum values of five blank samples were counted in each experiment. The blank solution includes a generalized ‘test mixture minus one of the following, activating part of Ca2+, CaM, MLC or MLCK. Experiments with blank counts higher than 300 cpm were excluded. The acidification of the sarcophagus can be carried out for 5 minutes and is evaluated by a count of 32 PM integrated into the MLC using a tm Analysis model 5303 Mark V liquid flash counter. The signal includes bursts with repeated high frequency waveforms. In all exposures, the amplitude was maintained at G.2G and the repetition rate was 丨burSt/see. Burst_ varies from 65 jusec to lOOOusec, according to the projection of the p0WerSNR analysis, which shows an optimized Power SNR analysis when the burst period is close to 5 sec. The results are shown in Figure 7, where the burst width 701 is the X-axis in nsec and the myosin phosphorylation is treated = sham is the Y-axis. It can be seen that the effect of PMF on the combination of Ca2+ and CaM reaches a maximum of nearly 50 〇 nsec, as explained by the power SNR model. These results demonstrate that the PMp signal configured in accordance with a preferred embodiment of the present invention will greatly increase myosin phosphorylation during a burst period sufficient to achieve an optimized p〇werSNR for a given magnetic field amplitude. 26 200824744 TPPO/PUS213-001 Example 2 In a preferred embodiment of the present invention, the use of the power SNR model further confirms the in-vivo wound repair model. The rat wound model has been well described in biomechanics and biochemistry and is used in this study. This study used a healthy, young adult male, Sprague Dawley over 300 grams. • Animals were anesthetized with intraperitoneal Ketamine 75 mg/kg and Medetomidine 0.5 -·mg/kg. After adequate anesthesia, remove the hair from the back, prepare a diluted sputum/alcohol solution' and cover it with sputum. Using a scalpel, gcm linearly cuts the skin to the bandage of each rat's back. The wound edge causes any residual skin fibers to be directly destroyed, leaving an open wound of approximately 4 cm in diameter. The hemostasis effect is achieved by applying pressure to avoid any damage to the edges of the skin. The edges of the skin are then sutured continuously with 4-〇 Ethil〇n. After the operation, butyl morphine and phlegm and phlegm and 5 mg/kg were applied to the animal's surface. They were placed in separate cages to receive food and water ad libitum. • PMF exposure includes two pulsed RF waveforms. The first is a fresh clinical PRF signal containing a 65-barrier burst with a 27.12 MHz sine wave and an i-Gaussian amplitude covering 600 bursts/sec. The second is a reorganization of the Qing signal according to a preferred embodiment of the present invention. This shop burst increased to 2 sec and the amplitude and repetition rate were reduced to 〇. 2G and 5 bursts/sec, respectively. Use PRF twice daily for 3 minutes each time. Tensile strong silk touch _ earned after. The _ wide- sized strip is cut from the vertical line of the flaw of each sample and used to measure the tensile strength, with peak/coffee 2 as the single 27 200824744 TPPO/PUS213-00. The strips were removed from the same area of each mouse to ensure the measurement-performity. The strip is then placed on the tension meter. The strip is loaded with 1Gram/min and the recording surface is turned over. The final comparison of the tensile thief is the average of the maximum loads of the two strips taken in the same wound, in kg/mm2. The experimental silk shows that for the 65 qing 1 G sense PRF signal, the average tensile strength is only for the test, and 疋 19. 3 ± 4 · 3 kg / mm 2 , the control group is 13 · 〇 ± 3.5 / delete 2 (Ρ<· 01), which has a touch increment. In contrast, for the _Fus 2 Gauss PRF signal configured by the SNR model according to the preferred embodiment of the present invention, the average tensile strength is 21.2 ± 5.6 kg/ugly 2 for the experimental group and i3 for the control group. ? * 4.丨_ (ρ<· 01) It has 540! . The results of these two signals are not significantly different. These knots and the 'Yangzhi'---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- According to a preferred embodiment of the present invention, the repair of the wound in the low-power mode in the 昧▲ type is more than two orders of magnitude more power than a clinical one. Example 3 The PRF electromagnetic field of the neuron is passed through the powerSNR method in the culture. The nutrients are built by the midbrain of the 15'16 day embryonic period of the embryonic period, / mechanically pulverized, decomposed into single cells, and the cells are placed in the medium or serum-containing medium. The cells were cultured in 6 days to obtain the adjusted medium after the meta-mature has been developed to make them a ^ 28 200824744 TPPO/PUS213-001. Enzyme-linked immunosorbent assays ("ELISAs) for growth factors such as fibroblast growth factor beta (" FGFb, r) are used to quantify the amount of their release to the vehicle. Dopamine neurons can be used with anti-probiotic [ammonium] The acid-chemical enzyme CTH") recognizes the enzyme that converts the amino acid tyrosine to L-d〇pa, a dopamine precursor, because dopamine neurons are the only ones that produce this enzyme in this system. cell. The quantification of cells was counted by counting TH+ cells under vertical strips across the cultured melon, 1 〇〇χ magnification.

Also contains nutrients and growth factors that support the survival of nerve cells. Removal of serum can lead to the death of nerve cells. Change the medium and expose the cells to ρΜρ (power level 6, burst width 3GG0usec, frequency〗. Use four subgroups. Groups) do not use PMF exposure (blank group). Group 2 uses pre-treatment (pre-treatment before moderate changes) 2 hours). Group 3 was treated after use (2 hours after moderate changes). Group 4 used direct treatment (at the same time with moderate changes). The results showed that before the culture was removed from the serum When exposed to p wins, more than two days later

There is an increase in the number of nicotinary neurons that survive. Other treatments have no significant side effects on neuronal population. The results are shown in Figure 6, where the treatment pattern is shown on the X-axis and the number of neurons is shown on the γ-axis. "As shown in Figure 7, the treatment of the towel is shown in the road, the number of neurons is shown on the Y-axis, and this B ^ 'PMF signals D and E decrease the concentration in the serum medium, and the number of amines & 46% right. Both sides of the statement are configured with burst width 3__ interest rate is 5/sec and 1/sec respectively. Obviously, the signal ^ is continuously _ Authentic execution, but the signal Ε is only executed once: 2 hours before the removal of 29 200824744 TPPO/PUS213-001 is the same (Mc see above), resulting in the value of the fruit sold <樵 and 48%). Due to the reduction of serum in the media, the availability of nutrients and growth factors is reduced, after going through The synthesis or release of these factors is induced by the cultivation of these factors. The role of this part of the experimental 6-inducing layer-induced toxicity produces a clearly described mechanism of dopamine cell death. This molecule is transported by high affinity dopamine. The daughter enters the cell and inhibits the enzyme complex j of the granulosa, and then kills these nerves via oxidative stress. The culture is treated with 25 μΜ 6-0 HDA after continuous or acute pmp exposure. Its towel Shown on the X-axis, the number of neurons is not on the γ-axis. Toxins kill about 8% of dopamine neurons in the absence of PMF treatment. Use under PMF (power: 6; burst width = 3Q_sec; frequency = 1) /sec), the survival of nerve cells is greatly increased compared to the only 6-〇HDA (2.6-fold; Ρ£〇·〇2), and the neuroprotection developed for Parkinson's disease is presented. The method is particularly relevant, and the oral 60 0A is used to impair dopamine in the Parkinson's standard scorpion animal model, and the binary and sputum mechanisms are somewhat similar to those of Parkinson's disease itself. In this example, electromagnetic field energy is used to stimulate the angiogenesis of the tube in an in vivo model. Two different signals are used, one according to the prior art configuration and the other according to the embodiment of the invention. One hundred and eight each The e-Dawley male, which weighs about 3 grams, is divided into nine groups. All animals are anesthetized with ketamine/acepr〇mazine/Stad〇1 mixture 〇·1 cc/g. Using sterile surgical techniques with microsurgical techniques Each animal takes 30 200824744 TPP O/PUS213-001 A 12 to 14 cm tail artery. The artery is filled with 60 U/ml heparinized salt to remove all blood or emboli. These average diameters are 4 mm to 0.5 mm of the tail vessel and then sutured to A cross-section of the right thigh bone artery closest to the end, using a two-to-end joint method to create a thigh bone arterial ring. The resulting loop is then placed in a subcutaneous pocket made in the animal's gastrointestinal tract / hamstring muscle tissue. The squirrel incision was sutured with 4-0 Ethilon. Then each animal was randomly placed into one of nine groups: groups 1 to 3 (control group), these mice were not connected _ subject to electromagnetic field treatment and killed after 4,8 weeks; groups 4 to 6, treatment each Twice a day, mother 30 points #里' use 〇· 1 Gauss electromagnetic field lasts 4,8,12 weeks (animals are killed after another 4,8,12 weeks); treatment twice daily, 3 times each time Minutes, using a 2 〇 Gauss electromagnetic field lasted 4 ' 8 ' 12 weeks (animals were killed after 4, 8, 12 weeks). Pulsed electromagnetic energy is applied to the treated group, using a slap made in accordance with an embodiment of the present invention. The animals in the test group received twice daily treatment, each go minutes, 〇. 1 Gauss or 2.0 Gauss, using short pulses (2 milliseconds to 20 milliseconds) 27.12 MHz. The object is placed over the top of the applicator and is restrained to ensure proper treatment. The ketamine/acepromazine/Stadol was beaten in the pneumoperitoneum and heparin 100 g was administered intravenously for re-anesthesia. Using a previous murine incision, the femoral artery can be clearly discerned from the plate's thigh/tail arterial ring and then proximally isolated from the junction, and the blood g is clamped to kill the animal. This circle was injected with a colored dressing with a salt of 0·5 cc to 1·Occ: a ribbed catheter and clamped. Carefully cut the skin above the abdomen and sway it*. The quantification of vascular puncture is quantified by the method of intraluminal administration of the surface of the vascular endothelium 31 200824744 TPPO/PUS213-001. After the money SPSS statistical analysis k body for all results were analyzed. In the blood &amp; newborn gamma treatment 彳 | and did not, practice the old gas, the most obvious _ difference occurred in the brother 4 weeks. During this period, no new blood vessel formation was observed in the control group. However, the group treated with the solidification had a similar sigmoidal evidence for angiogenesis in G cm2 versus 142 ± G 8Q — (p < 01). . These areas appear when the milk is distributed in sections along the sides of the - arterial ring. At 8 weeks, the control group began to exhibit an angiogenic effect, measured in Φ.7 〇·82 cm2. The two treated groups again had almost the same statistical significance at 8 weeks (p &lt; 0. coffee) vascular exposure, 3.57 ± L 82 cm2 for G. 〗 chest contrast group ' 3. 77 ± 1.82 cm2 for the 2. Ggauss group. At 12 weeks, the animals in the control group exhibited an angiogenic effect of 1.75±0.95αη2, while the 〇. i § 面 group exhibited 5.95 ± 3· 25 cm2, 2.0 gauss group showed 6. 2〇± &amp; 95 - the formation of dendritic blood vessels. Again, the two treatment groups again showed a statistically significant (P &lt; 0 001) finding comparable to the control group. • The results of these experimental studies show that the electromagnetic field stimulation of an isolated arterial ring according to the embodiment of the present invention greatly increases the angiogenesis effect in a living mouse model. Increased angiogenesis is shown in the treatment group. No difference was found in the two Gaussian level tests, as in the present invention. In the above specific embodiment, the integrated coil device for treating human and animal cells, tissues, and organs by electromagnetic field and the method thereof can be used without leaving the day and the moon. 32 200824744 ^ TPPO/PUS213- 001 &amp; This feature is all kinds of tenderness. The tree-shaped axis is limited by the scope of the patent application of the attached file, and the change of the face-to-face is required to be included in the present invention. BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a flow chart showing the use of a __&lt;_ type of treatment method integrated into a preferred embodiment of the preferred embodiment of the present invention. 2 is a schematic view of an electromagnetic therapeutic apparatus according to a preferred embodiment of the present invention. 3 is a circuit diagram showing the miniaturization of the preferred embodiment of the present invention. Figure 4 is a perspective view of the preferred embodiment of the present invention. Figure 5 is a bar graph illustrating the PMF pre-treatment results, wherein 5i is no application, before applying force σ PMF, 53 is after applying PMF, Figure 6 A bar graph to illustrate the results of a particular PMF. Figure 7 is a bar graph illustrating the results of persistent PMF. [Description of component number] 201 micro control circuit 202 connector 203 generating device 300 micro control circuit 33 200824744 TPPO/PUS213-001

301 lithium battery 302 adjustable power supply 303 microcontroller 304 storage capacitor 305 pulse forming machine 306 pulse phase time controller 307 voltage level conversion secondary circuit | 308 adjustable HEXFET 309 output 400 waveform 401 pulse 402 burst 404 amplitude packet 34 during 403

Claims (1)

200824744 TPPO/PUS213-001 X. Patent Application Scope 1. A method for electromagnetic treatment of animals and humans, the method comprising the steps of: arranging at least one according to a mathematical model having at least one waveform parameter a waveform that is combined with a target path structure; selecting at least one value of the waveform parameter to cause at least one of the waveforms to be detectable in the target path structure over the target path structure background activity Detecting; generating an electromagnetic signal from the configured waveform; integrating at least one of the bonding devices with a placement device to be placed in proximity to the target path structure; and combining at least one of the bonding devices The electromagnetic signal is applied to the target path. 2. The method of electromagnetic therapy for animals and human ships, as claimed in the patent specification, wherein at least one of the waveform parameters comprises: at least one frequency component of the parameter 1 is configured to = the waveform is approximately repeated Engraved. (10)z to (10) test, - burst vibration package 其 $ which is derived from the mathematically defined amplitude function, : Tian, learning definition __ 赖_魏, mathematically defined amplitude function in the target structure In the second:: according to Wei Wei changes, and a peak induced magnetic field parameters basis - mathematics fixed shame ^ Fan path structure in about 1 rainbow to G.1 van _ change. "The number of the axis treatment in this target and humans. 3. For the animal 200824744 TPPC/PUS213-001 method described in claim 2, wherein the defined amplitude function comprises: at least one v-frequency function, An ugly function, a chaotic function, and an exponential function. The method for electromagnetic treatment of animals and humans as described in the patent item i, wherein the step of selecting at least one value of the waveform parameter is more The method includes the step of selecting a value of the waveform parameter that satisfies at least one of the domain-to-noise mode s. • 5. The method for electromagnetic treatment of animals and humans as described in claim i, wherein The step of selecting at least one value of the waveform parameter further comprises the step of selecting a value that satisfies at least one of the power signal to the noise ratio model. 6. For example, the sub-item of the claim 5 The method for electromagnetic treatment of animals and humans, wherein the target heterostructure comprises at least one molecule, cell, tissue, organ, ion, and ligand. 1 tearing on the axis and human face electromagnetic treatment method ^ which further includes the steps of combining ions and heterozygote to the trans-molecule for face growth, repair, and maintenance. ^As described in the scope of claim 7 The practice of electromagnetic therapy with humans' where the combination of the ion and the ligand contains a combination of regulation of the mother and the simple element. 36 200824744 Manufacture of TPPO/PUS213-001. As described in claim 7 for animals and A method of electromagnetic therapy in humans, wherein the binding of the ion to the ligand comprises modulating a cytokine in the target pathway structure. The method of electromagnetic treatment of animals and humans as described in the seventh application of the patent application The age of rape includes growth factors and cytokines related to non-woven silk, health and maintenance. 12. The method of electromagnetic treatment for animals and humans as described in the patent application item 7 The knot contains pure blood transfusion and neovascularization to carry out the growth, repair, and maintenance of the target path structure. 13·If the scope of the patent application is 7th, the lion will perform electromagnetic therapy on silk and humans. The method wherein the binding of the ion to the ligand comprises regulating angiogenesis and neovascularization for the treatment of cerebrovascular diseases. 37 200824744 TPPO/PUS213-001 14 · For animals and humans as described in claim 7 A method of performing electromagnetic therapy, wherein the binding of the ion to the ligand comprises the treatment of a growth factor and a cytokine for the treatment of sleep disorders. The method for electromagnetic treatment of animals and humans as described in claim 7 of the patent application, wherein The combination of the ion and the ligand includes a method for regulating angiogenesis and neovascularization for sleep disorder, and a method for treating the symphysis, wherein the ion and the ligand are used. The combination involves the regulation of the release of human growth hormone by increasing the length of the deep eye stage. 17. The method of electromagnetic treatment of animals and humans as described in item yi of the patent application PCT, which further includes the use of _ and herbal fiber in the target heterostructure for tissue growth, repair, and maintenance. ^申糊细Π Π 状 和 和 和 和 和 和 和 和 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦 迦The party 38 200824744 TPPO/PUS213-001 method, which further comprises the application of medicaments and herbal agents to the target path structure for the treatment of neurodegenerative diseases. 2. The method of electromagnetically treating animals and humans as described in claim 1, wherein the setting device comprises at least one of the following: ', therapeutic surface, therapeutic structure, therapeutic device, surgical dressing, anatomical support , anatomical entanglement, wound dressing, sputum, seat scorpion, mattress, shoes, (four), Xuan, cell structure. 21. A method of electromagnetic treatment of animals and humans as described in claim 2, wherein the garment comprises at least the following: clothing, fashion accessories, shoes, machines, and foot items. 22. A method of electromagnetically treating an animal and a human as described in claim i, wherein the bonding device comprises at least one wire and a coil. If you apply for a patent scope! The method of electromagnetic treatment of animals and humans as described therein further includes the step of applying standard physical and therapeutic therapies to treatment in a body region. 24 The method of electromagnetic therapy for secret and human beings, as stated in the 23rd of the application, wherein the standard physical therapy includes at least one of the following: heat, cold, pressure, massage 39 200824744 TPPO/PUS213-001 and exercise. A. For example, the method of applying electromagnetic therapy to animals and humans as described in the application of the patent Lai i, which is the step of setting up the feeding and digging the drums. 2 = such as 25 jobs _ 姊 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ The waveform. The method for electromagnetic treatment of animals and humans as described in the patent specification, further includes the step of continuously generating one magnetic signal to at least one of the plurality of combined devices. / The method of electromagnetic therapy for animals and humans as described in claim 27 of the patent application, wherein the electromagnetic signal is generated by at least the following: at least one of the same configuration, and at least one of the different configurations The waveform of one. It is said that the method of electromagnetic treatment for animals and humans as described in item i of the patent application further includes the step of multi-transferring one magnetic recording age. The method of electromagnetically treating animals and humans according to claim 29, wherein the electromagnetic signal is generated by at least one of the following: at least one of the same configuration. The waveform, and the waveform of the different at least one configuration. The method of electromagnetic therapy for animals and humans as described in the first application of the patent application, which further includes the use of at least one of standard medical therapy and non-standard medical therapy with the gas stone treatment-inducing device. step. Patent application for the electromagnetic treatment of animals and humans as described in item 31 of the patent application. The standard medical therapy includes at least the following L-plants, and the method of electromagnetic treatment for animals and humans as described in Patent Item 1 Look for the German fresh medicine to turn the silk _ quasi-radiation treatment of a small amount of money to turn the stone Shiz treatment treatment device connected to use the steps. ^ /, medium standard physiotherapy includes at least one of the following /, hot, cold, scale, and tender. (iv) Side, positive pressure, as described in item 1 of the patent application scope for animals and humans to 'incorporate the electromagnetic signal Wei target path, % of the party contains the cells and the loss of the 200824744 TPPO/PUS213-001 tissue and a combination of degradation. 36. A method of electromagnetic treatment of lees, humans and humans as described in claim 1 of the scope of patent application, wherein the combination of the activity of the lion's tissue. 37. A method of electromagnetic treatment of a Dingle object and a human as described in claim 1 of the patent application, in which a combination of the electromagnetic code is combined. See the method of applying for special treatment _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ For example, the method of electromagnetically treating animals and humans as described in claim i, wherein the step of combining the electromagnetic signal to the target comprises increasing the combination of the number of neurons. The method of electromagnetically treating animals and humans as described in the above-mentioned patent application, wherein the electromagnetic signal is combined with the deterioration of the target path junction neuron. Upper gland 42 200824744 TPPO/PUS213-001 41·If you apply for a patent! The method of electromagnetically treating animals and humans as described in the section wherein the step of binding the electromagnetic signal to the target pathway structure comprises increasing the binding of the number of adrenal neurons. 42. A method of electromagnetically treating an animal and a human as described in the application of the patent item i, wherein the step of generating a magnetic signal from at least one of the configured waveforms comprises programmably generating the electromagnetic signal . 43. An electromagnetic treatment device for animals and humans, comprising: - a waveform configuration for configuring at least a side waveform to be coupled to a "target path structure," according to a mathematical mode; the mathematical mode having at least one The waveform parameter is selectable 'such that at least one of the waveforms is configured to be detectable in the target path structure above the target path structure background activity. At least the combination device is coupled to the waveform configuration via at least one side connection for generating an electromagnetic signal from the configured at least one waveform and for combining the electromagnetic signal to the The target road grip structure; and the at least one of the placement devices are part of the placement device. 44. The electromagnetic therapeutic apparatus for animals and humans according to claim 43, wherein the waveform parameter of at least one of the at least one of the following: 43 200824744 TPPO/PUS213-001 ^Fresh 'shouting parameter, The number of gift-numbers is _ _ _ between about 0·01Ηζ to 100MHz; - the burst amplitude packet parameter, which is obtained according to the mathematically defined amplitude function. - The ship's parameter' is based on the mathematics Variations in the sinusoidal repeats; - peak profile, varying between about 1 μν/cm and 100 mV/αη in the fine target path function; and between about 1 liT and 0·1T in the target path function . The number function, a chaotic function, and an exponential function are as described in claim 43. The amplitude function of the soft sense includes at least the following: - 17 frequency function, a pair of 46 The electromagnetic therapy device for animals and humans as described in claim 43 is characterized in that at least one of the waveform parameters further includes one of the waveform parameters satisfying at least one of the signal noise ratio models. value. 47. The electromagnetic therapy device for animals and humans according to claim 43 of claim 4, wherein at least one of the values of the waveform parameter further comprises at least one of the power signal noise modulo! A value of the waveform parameter. </ RTI> </ RTI> </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; And matching seats. 49. The electromagnetic treatment device for animals and humans described in Item 43 of the patent scope of the application, the L-type 疋 is inductively coupled to the target path structure, wherein the combination of dance and lycopene is Regulated. 50. An electromagnetic therapeutic rupture for animals and humans as described in claim 43 wherein the signal is capacitively bound to the target heterostructure, wherein the transflex binding is regulated. 51. The electromagnetic therapeutic device for animals and humans as described in claim 43 wherein the domain is inductively coupled to the target path structure to regulate growth, repair, and maintenance of the target path structure. Growth of the production of axonal hormones. 52. The electromagnetic therapy device for animal and human use as described in claim 51, the medium growth factor comprises at least one of the following: fibroblast growth factor, platelet release growth liver, and inter Born. 45 200824744 An electromagnetic treatment device for animals and humans as described in claim 43 wherein the signal is capacitively coupled to the target path structure to regulate the growth, repair, and maintenance of the eyeless structure. Growth factor or production of cytokines. 54 such as the Shenzi Na 53 lion (four) paste magnetic treatment device, wherein the butterfly contains at least the following - fibroblast butterfly, platelet release growth factor, and white matter growth factor. 55. The electromagnetic therapeutic device for animals and humans described in the patent application No. 43, "U-Tiger is electrically connected to the target path structure to protect the angiogenesis and neovascularization of the bone fracture ^ Gentleman's claim for the electromagnetic treatment device for animals and humans described in Item 43 of the patent, the U-infant is inductively coupled to the target path structure, and the gray tube newborn and newborn for the treatment of bone fracture Vascular effect. &lt; σ , 申 申 申 申 申 申 申 申 申 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁 电磁Acting, , 58· Electromagnetic treatment equipment for animals and humans as described in the scope of the patent application No. 46 200824744 TPPO/PUS213-OOI blood tube:=:r--m mΓ娜43 The object is called a human-type treatment device, in which the sputum is inductively coupled to the pulverized contact area of the target road therapy. &amp; fine-cutting and escaping disease treatment 60. As described in claim 43 Set, Fuzhong Renxin Year ~, animals and people An electromagnetic treatment apparatus Bu "domain is bound to the valley% target hybrid structure FSC neovascularization angiogenesis regulation Ye therapeutic treatment of vascular diseases acting. The electromagnetic therapy device for animals and humans described in Item 43 of the patent scope is capacitively coupled to the target structure to regulate the vascular contact surface of the disease treatment. 6 2 7 The patent and the human _ magnetic therapy device, the mid-domain is inductively coupled to the target pathway structure to regulate the angiogenesis and neovascularization for sleep disorder treatment. /σ Women's Declared Patent 帛 帛 于 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物 动物With the role of new blood vessels. 64. An electromagnetic therapeutic device for animals and humans as described in claim 43 wherein the signal is inductively coupled to the target pathway structure to increase the production of human growth factors by increasing deep sleep time. 65. An electromagnetic therapeutic device for animals and humans as described in claim 43 wherein the signal is capacitively coupled to the target pathway structure to increase the production of human growth factors by increasing deep sleep time. 66. An electromagnetic treatment device for animals and humans as described in claim 43 wherein the electromagnetic treatment device is made lightweight and portable. 67. The electromagnetic treatment device for animals and humans as described in Item 43 of the application of the patent, wherein the installation device comprises at least the following:: silk surface treatment, treatment structure, treatment equipment, surgical dressing, anatomy Support, disintegration, wound dressing, pad, seat, mattress Pf, clothing, shaft and structure that can be placed close to living tissue and cells. ===== 48 200824744 and foot products TPPO/PUS213-001 69. If applying for a reversal, the connection method includes at least;; = electromagnetic treatment of animals and humans, and direct connection 1 -: wire, wireless signal transmission and reception 43 type of money in which the form is set to be programmable. The method is set in the __ county mosquitoes __ hand to the pulse magnetic field 1 Lu Shu 0 72 · as described in the scope of claim 43 for the animal and human set /, the waveform configuration mode in a random time Mark. The electromagnetic treatment of the class carries at least one pulsed magnetic field signal 74 as described in the scope of patent application 帛 73. The electromagnetic treatment device for animals and humans 49 200824744 TPPO/PUS213-001 as described in claim 43 Use, which contains the needle and the herbal agent - the way of transmission. Magnetic therapy equipment The electromagnetic treatment equipment for animals and humans mentioned in Item 43 is more suitable for the transfer of the standard to the transfer method. 7?? The scope of the scope of the 76th electromagnetic therapy treatment for animals and humans I ^ medical treatment includes at least the following treatment: neovascularization, blood, birth, heart and benign immunity Reaction, and treatment of exudation. The electromagnetic treatment device for animals and humans described in Item 43 of the patent "This wave configuration is integrated with the placement device. One of the magnetic therapy devices can be discarded. 79. The invention is for use in animals and humans, wherein the device is at least portable, implantable, and seeded. 80. The electromagnetic treatment device for animals and humans according to claim 43 of the patent application, The method further includes a plurality of at least one combination device for simultaneously generating at least one electromagnetic signal from at least one configured 50 200824744 TPPO/PUS213-001 waveform. For example, as described in claim 8 For animal and human-electromagnetic therapy devices, wherein the waveform of at least one of the configurations comprises at least one of: at least one waveform of the same configuration, and at least one of the different configurations of the waveform. The invention relates to the animal and the human-electromagnetic therapeutic device, wherein the method further comprises at least one of a plurality of combined devices for configuring the waveform by at least one configuration. And continuously generating at least one electromagnetic signal. 83. The electromagnetic therapy device of the animal and human being as described in claim 82, wherein at least one of the configurations of the wave is full of at least one of the following The waveform of at least one configuration, and the waveform of at least one of the configurations. • 84· * Patent application of the 43rd item of the animal and human electromagnetic treatment equipment • At least one of a combination of a device for multiplexing at least one electromagnetic signal from a waveform of at least one configuration. 85. An electromagnetic type for animals and humans as described in claim 84 The treatment device, wherein the waveform of the configuration of at least one of the at least one of the following: the waveform of the same at least one configuration, and the waveform of the different at least one configuration. 51 200824744 TPPO/PUS213-001 86. The vine animal and human _ electromagnetic treatment device according to item 43, wherein 彳§ is inductively coupled to the target path structure. 87. The vine animal and human electromagnetic treatment device, wherein the signal is capacitively coupled to the target path structure. ^ 88. The electromagnetic treatment device for animals and humans as described in claim 43 Wherein the signal is inductively coupled to the target path structure to prevent loss and degradation of cells and tissues. 89. The electromagnetic therapeutic device of the animal and human body described in claim 43 of the patent application, wherein the signal is capacitively Incorporating the target path structure to prevent loss and degradation of cells and tissues. The electromagnetic therapy device for animals and humans as described in claim 43 wherein the signal is inductively coupled to the target Path structure to enhance cell viability. 91. An electromagnetic therapeutic device for animals and humans as described in claim 43 wherein the signal is capacitively coupled to the target pathway structure to enhance cellular activity. </ RTI> </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> <RTIgt; 93. An electromagnetic therapeutic device for animals and humans as described in claim 43 wherein the signal is capacitively coupled to the target pathway structure to increase the number of cells. 94. For use in animal and human-electromagnetic treatment devices as described in claim 43 wherein the signal is inductively coupled to the target structure to prevent neuronal decay. 95. If the application __ Item 43 (4) in the animal and human _ electromagnetic treatment device, where the domain is capacitively combined _ target road 9J ·, the middle domain is domain-type combination 〇, /, medium and compact capacitors . The decline of the Yuan Dynasty: K-Synthesis 4 to the fine _, the adrenal gland 53 200824744 TPPO/PUS213-001 The electromagnetic treatment device for animals and humans described in the 43rd patent application. ______ Retreat. 100• As described in Section 43 of the patent application, 罟甘+K is used in the electromagnetic therapy device for animals and humans, and the medium signal is inductively coupled to the target. The posterior sacral structure to increase the adrenal neurons 101. As described in claim 43, wherein the signal is capacitively coupled to the _2 object and the number of human electromagnetic therapeutic devices. V invasive structure to increase adrenal neurons 102. As claimed in the scope of the 43rd item, where the waveform configuration is programmable, the object and the person_electromagnetic treatment device 54